Loading...

Winston Resources

CNSX:WRW
Snowflake Description

Flawless balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
WRW
CNSX
CA$754K
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Winston Resources Inc. focuses on the cannabis business. The last earnings update was 78 days ago. More info.


Add to Portfolio Compare Print
WRW Share Price and Events
7 Day Returns
-
CNSX:WRW
-3.6%
CA Pharmaceuticals
-0.3%
CA Market
1 Year Returns
-76.9%
CNSX:WRW
-0.5%
CA Pharmaceuticals
-3.3%
CA Market
WRW Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Winston Resources (WRW) - 50% -40% -76.9% 500% -
CA Pharmaceuticals -3.6% -13.8% -16.7% -0.5% 632.4% 426.9%
CA Market -0.3% -1.2% -0.7% -3.3% 11.2% 0.5%
1 Year Return vs Industry and Market
  • WRW underperformed the Pharmaceuticals industry which returned -0.5% over the past year.
  • WRW underperformed the Market in Canada which returned -3.3% over the past year.
Price Volatility
WRW
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Winston Resources's competitors could be found in our database.

WRW Value

 Is Winston Resources undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Winston Resources is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Winston Resources has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Winston Resources. This is due to cash flow or dividend data being unavailable. The share price is CA$0.03.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Winston Resources's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Winston Resources's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:WRW PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-01-31) in CAD CA$-0.19
CNSX:WRW Share Price ** CNSX (2019-06-10) in CAD CA$0.03
Canada Pharmaceuticals Industry PE Ratio Median Figure of 11 Publicly-Listed Pharmaceuticals Companies 21.06x
Canada Market PE Ratio Median Figure of 547 Publicly-Listed Companies 15.02x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Winston Resources.

CNSX:WRW PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:WRW Share Price ÷ EPS (both in CAD)

= 0.03 ÷ -0.19

-0.16x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Winston Resources is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Winston Resources is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Winston Resources's expected growth come at a high price?
Raw Data
CNSX:WRW PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.16x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.16x
Canada Market PEG Ratio Median Figure of 247 Publicly-Listed Companies 1.14x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Winston Resources, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Winston Resources's assets?
Raw Data
CNSX:WRW PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-01-31) in CAD CA$0.00
CNSX:WRW Share Price * CNSX (2019-06-10) in CAD CA$0.03
Canada Pharmaceuticals Industry PB Ratio Median Figure of 145 Publicly-Listed Pharmaceuticals Companies 2.69x
Canada Market PB Ratio Median Figure of 2,422 Publicly-Listed Companies 1.41x
CNSX:WRW PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:WRW Share Price ÷ Book Value per Share (both in CAD)

= 0.03 ÷ 0.00

-15.95x

* Primary Listing of Winston Resources.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Winston Resources has negative assets, we can't compare the value of its assets to the CA Pharmaceuticals industry average.

Next steps:

  1. Examine Winston Resources's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Winston Resources's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Pharmaceuticals industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Winston Resources's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Winston Resources has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

WRW Future Performance

 How is Winston Resources expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Winston Resources has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
88.2%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Winston Resources expected to grow at an attractive rate?
  • Unable to compare Winston Resources's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Winston Resources's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Winston Resources's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:WRW Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 88.2%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 54.9%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:WRW Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:WRW Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-01-31 0 -5
2018-10-31 0 2
2018-07-31 -1 2
2018-04-30 0 0 6
2018-01-31 -1 6
2017-10-31 -2 -1
2017-07-31 -1 -1
2017-04-30 -1 -2
2017-01-31 0 -1
2016-10-31 0 0
2016-07-31 0 0
2016-04-30 0 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Winston Resources is high growth as no earnings estimate data is available.
  • Unable to determine if Winston Resources is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:WRW Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Winston Resources Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:WRW Past Financials Data
Date (Data in CAD Millions) EPS *
2019-01-31 -0.19
2018-10-31 0.08
2018-07-31 0.07
2018-04-30 0.23
2018-01-31 0.24
2017-10-31 -0.07
2017-07-31 -0.08
2017-04-30 -0.27
2017-01-31 -0.28
2016-10-31 -0.04
2016-07-31 -0.05
2016-04-30 -1.18

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Winston Resources will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Winston Resources's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Winston Resources's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Winston Resources's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Winston Resources's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Winston Resources has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

WRW Past Performance

  How has Winston Resources performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Winston Resources's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Winston Resources does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Winston Resources's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Winston Resources's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Winston Resources's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Winston Resources Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:WRW Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-01-31 -4.68 0.44
2018-10-31 1.90 0.51
2018-07-31 1.81 0.59
2018-04-30 0.00 6.10 0.52
2018-01-31 5.71 0.88
2017-10-31 -1.21 1.14
2017-07-31 -1.04 0.98
2017-04-30 -1.64 0.90
2017-01-31 -0.91 0.39
2016-10-31 -0.14 0.01
2016-07-31 -0.15 0.02
2016-04-30 -3.87 0.05
2016-01-31 -4.12 0.04
2015-10-31 -4.52 0.05
2015-07-31 -4.53 0.07
2015-04-30 -2.18 0.11
2015-01-31 -2.18 0.15
2014-10-31 -2.19 0.17
2014-07-31 -2.22 0.18
2014-04-30 -1.33 0.98
2014-01-31 -1.21 1.12
2013-10-31 -1.67 1.20
2013-07-31 -1.79 1.35
2012-07-31 -1.30 0.67

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Winston Resources has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Winston Resources has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Winston Resources improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Winston Resources's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Winston Resources has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

WRW Health

 How is Winston Resources's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Winston Resources's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Winston Resources is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Winston Resources has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Winston Resources's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Winston Resources has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Winston Resources Company Filings, last reported 4 months ago.

CNSX:WRW Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-01-31 0.62 0.00 0.65
2018-10-31 0.69 0.00 0.82
2018-07-31 0.78 0.00 0.87
2018-04-30 3.86 0.00 0.93
2018-01-31 9.51 0.00 1.00
2017-10-31 1.79 0.00 1.07
2017-07-31 1.96 0.00 1.45
2017-04-30 2.09 0.00 1.81
2017-01-31 -0.54 0.15 0.00
2016-10-31 -0.14 0.10 0.00
2016-07-31 -0.13 0.00 0.00
2016-04-30 -0.12 0.00 0.00
2016-01-31 -0.30 0.01 0.00
2015-10-31 -0.90 0.12 0.00
2015-07-31 -0.88 0.03 0.00
2015-04-30 4.55 0.00 0.00
2015-01-31 4.61 0.00 0.00
2014-10-31 4.64 0.00 0.01
2014-07-31 4.49 0.00 0.00
2014-04-30 6.90 0.02 0.05
2014-01-31 6.97 0.01 0.02
2013-10-31 6.87 0.04 0.03
2013-07-31 6.82 0.00 0.05
2012-07-31 7.99 0.06 0.55
  • Winston Resources has no debt.
  • Winston Resources has no debt compared to 5 years ago when it was 0.2%.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Winston Resources has sufficient cash runway for 1.9 years based on current free cash flow.
  • Winston Resources has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 36.1% each year.
X
Financial health checks
We assess Winston Resources's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Winston Resources has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

WRW Dividends

 What is Winston Resources's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Winston Resources dividends.
If you bought CA$2,000 of Winston Resources shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Winston Resources's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Winston Resources's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:WRW Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.7%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Winston Resources has not reported any payouts.
  • Unable to verify if Winston Resources's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Winston Resources's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Winston Resources has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Winston Resources's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Winston Resources afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Winston Resources has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

WRW Management

 What is the CEO of Winston Resources's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Quinn Field-Dyte
COMPENSATION CA$33,500
TENURE AS CEO 2.3 years
CEO Bio

Mr. Quinn Field-Dyte has been the Chief Executive Officer of Winston Resources Inc. since March 30, 2017 and has been its Interim Chief Financial Officer and Secretary since February 7, 2019. Mr. Field-Dyte has been the Chief Executive Officer and President of Hadley Mining Inc. since December 30, 2016 and March 29, 2016 respectively. He serves as the Chief Financial Officer of Hadley Mining Inc. He has been a Director of Hadley Mining Inc. since December 30, 2016. Mr. Field-Dyte has been a Director of Winston Resources Inc. since December 30, 2016.

CEO Compensation
  • Quinn's compensation has increased whilst company is loss making.
  • Quinn's remuneration is lower than average for companies of similar size in Canada.
Management Team

Quinn Field-Dyte

TITLE
CEO, Interim CFO
COMPENSATION
CA$34K
TENURE
2.3 yrs

Ron Lazof

TITLE
Strategic Consultant
AGE
68
TENURE
6.9 yrs
Board of Directors Tenure

Average tenure of the Winston Resources board of directors in years:

2.3
Average Tenure
  • The average tenure for the Winston Resources board of directors is less than 3 years, this suggests a new board.
Board of Directors

Quinn Field-Dyte

TITLE
CEO, Interim CFO
COMPENSATION
CA$34K
TENURE
2.5 yrs

Gordon Jang

TITLE
Chairman of Advisory Board
AGE
53
TENURE
2.3 yrs

Suzette Ramcharan

TITLE
Independent Director
COMPENSATION
CA$10K
TENURE
2.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess Winston Resources's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Winston Resources has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

WRW News

Simply Wall St News

Should You Be Holding Winston Resources Inc (CNSX:WRW) Right Now?

Generally, an investor should consider two types of risk that impact the market value of WRW. … The second risk is market-wide, which arises from investing in the stock market. … A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one.

Simply Wall St -

Is It Time To Buy Winston Resources Inc (CNSX:WRW) Based Off Its PE Ratio?

and want to better understand how you can grow your money by investing in Winston Resources Inc (CNSX:WRW). … Winston Resources Inc (CNSX:WRW) is trading with a trailing P/E of 0.6x, which is lower than the industry average of 11.2x. … While WRW might seem like an attractive stock to buy, it is important to understand the assumptions behind the P/E ratio before you make any investment decisions

Simply Wall St -

WRW Company Info

Description

Winston Resources Inc. focuses on the cannabis business. The company is headquartered in Vancouver, Canada.

Details
Name: Winston Resources Inc.
WRW
Exchange: CNSX
Founded:
CA$754,015
25,133,840
Website: http://www.winstonresourcesinc.com
Address: Winston Resources Inc.
800-1199 West Hastings Street,
Vancouver,
British Columbia, V6E 3T5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX WRW Common Shares Canadian National Stock Exchange CA CAD 23. Oct 2015
DB WNT Common Shares Deutsche Boerse AG DE EUR 23. Oct 2015
Number of employees
Current staff
Staff numbers
0
Winston Resources employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/15 00:39
End of day share price update: 2019/06/10 00:00
Last earnings filing: 2019/03/29
Last earnings reported: 2019/01/31
Last annual earnings reported: 2018/07/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.